Literature DB >> 17430095

Autoimmune etiology in chronic prostatitis syndrome: an advance in the understanding of this pathology.

Virginia Elena Rivero1, Ruben Darío Motrich, Mariana Maccioni, Clelia María Riera.   

Abstract

The prostate is the target of many inflammatory and neoplastic disorders that affect men of all ages. Pathological conditions of the prostate gland range from infection of this organ by ascending bacteria from infected urine, to chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) of a still unknown etiology (accompanied with inflammation and lymphocyte infiltration of the gland), to benign hyperplasia and cancer. Patients under 50 years of age usually suffer from CP/CPPS, a chronic inflammatory syndrome characterized by pelvic pain, irritative voiding symptoms, and sexual dysfunction complaints. In this review, we summarize the current knowledge regarding immunological alterations present in CP/ CPPS patients. Remarkably, an inflammation state, in the absence of an invading infectious agent, is established in these patients, suggesting that an autoimmune process could be involved. In fact, specific autoimmune response to prostate antigens has recently been reported in CP/CPPS patients. Autoimmune response to prostate gland affects the seminal quality reported in these patients and may have critical consequences in their fertility. It is anticipated that preclinical studies in experimental models for CP/CPSS will provide important insights into the etiopathogenic mechanisms involved in this disease. We discuss here the similarities and the differences between human disease and experimental models and argue for the importance of the prostate gland in male reproductive function. Ultimately, we suggest that a state of inflammation, originally incited by an autoimmune response within the prostate, together with a diminished prostate functionality, may compromise male fertility.

Entities:  

Mesh:

Year:  2007        PMID: 17430095     DOI: 10.1615/critrevimmunol.v27.i1.30

Source DB:  PubMed          Journal:  Crit Rev Immunol        ISSN: 1040-8401            Impact factor:   2.214


  10 in total

1.  Novel Treatment of Experimental Autoimmune Prostatitis by Nanoparticle-Conjugated Autoantigen Peptide T2.

Authors:  Yijie Cheng; Yanfang Cao; Awais Ullah Ihsan; Farhan Ullah Khan; Xue Li; Dianyou Xie; Xingxing Cui; Wenlu Wang; Ziwei Liu; Cunyu Li; Khalil Ali Ahmad; Kiganda Raymond Sembatya; Reyaj Mikrani; Xiaohui Zhou
Journal:  Inflammation       Date:  2019-06       Impact factor: 4.092

2.  Histopathological classification criteria of rat model of chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Xianjin Wang; Shan Zhong; Tianyuan Xu; Leilei Xia; Xiaohua Zhang; Zhaowei Zhu; Minguang Zhang; Zhoujun Shen
Journal:  Int Urol Nephrol       Date:  2014-11-20       Impact factor: 2.370

3.  Biomarkers of systemic inflammation and risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.

Authors:  Jeannette M Schenk; Alan R Kristal; Marian L Neuhouser; Catherine M Tangen; Emily White; Daniel W Lin; Mario Kratz; Ian M Thompson
Journal:  Am J Epidemiol       Date:  2010-02-08       Impact factor: 4.897

4.  Long-term effects of acupuncture for chronic prostatitis/chronic pelvic pain syndrome: systematic review and single-arm meta-analyses.

Authors:  Zongshi Qin; Jiani Wu; Chang Xu; Xiaopu Sang; Xiao Li; Guangrui Huang; Zhishun Liu
Journal:  Ann Transl Med       Date:  2019-03

5.  Pain in chronic prostatitis and the role of ion channels: a brief overview.

Authors:  Asha Caroline Cyril; Reem Kais Jan; Rajan Radhakrishnan
Journal:  Br J Pain       Date:  2021-05-19

Review 6.  Immunological Mechanisms Underlying Chronic Pelvic Pain and Prostate Inflammation in Chronic Pelvic Pain Syndrome.

Authors:  María L Breser; Florencia C Salazar; Viginia E Rivero; Rubén D Motrich
Journal:  Front Immunol       Date:  2017-07-31       Impact factor: 7.561

7.  Pathogenic Roles of CXCL10 in Experimental Autoimmune Prostatitis by Modulating Macrophage Chemotaxis and Cytokine Secretion.

Authors:  Xiaoliang Hua; Shengdong Ge; Meng Zhang; Fan Mo; Ligang Zhang; Jiong Zhang; Cheng Yang; Sheng Tai; Xianguo Chen; Li Zhang; Chaozhao Liang
Journal:  Front Immunol       Date:  2021-09-29       Impact factor: 7.561

Review 8.  The effect of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) on semen parameters in human males: a systematic review and meta-analysis.

Authors:  Weihua Fu; Zhansong Zhou; Shijian Liu; Qianwei Li; Jiwei Yao; Weibing Li; Junan Yan
Journal:  PLoS One       Date:  2014-04-17       Impact factor: 3.240

9.  Regulatory T cells control strain specific resistance to Experimental Autoimmune Prostatitis.

Authors:  Maria L Breser; Andreia C Lino; Ruben D Motrich; Gloria J Godoy; Jocelyne Demengeot; Virginia E Rivero
Journal:  Sci Rep       Date:  2016-09-14       Impact factor: 4.379

10.  Resveratrol improves prostate fibrosis during progression of urinary dysfunction in chronic prostatitis by mast cell suppression.

Authors:  Huizhi Zeng; Yi He; Yang Yu; Jiashu Zhang; Xiaona Zeng; Fengtao Gong; Qi Liu; Bo Yang
Journal:  Mol Med Rep       Date:  2017-11-03       Impact factor: 2.952

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.